We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LZMH:NASDAQLZ Technology Holdings Limited Analysis

Data as of 2026-05-28 - not real-time

$1.28

Latest Price

9/10Risk

Risk Level: High

Executive Summary

LZ Technology (LZMH) is trading at $1.28, dramatically below its 20‑day ($1.72), 50‑day ($12.52) and 200‑day ($38.99) simple moving averages, indicating a deep bearish bias. The RSI of 21.8 signals oversold conditions, while the MACD histogram is positive and the MACD signal is deemed bullish, hinting at a potential short‑term technical rebound. Fundamentally, the company posted a staggering 91% revenue surge yet posted operating losses of nearly 19% and a negative EPS of -3.33, with a debt‑to‑equity ratio above 100% and a max drawdown approaching 100%. The DCF‑derived fair value of roughly $17.66 suggests a massive valuation gap, but the extreme 543% 30‑day volatility, a negative beta of -1.80 and a market‑cap under $12 million amplify the risk profile. Recent material news of a 37% revenue increase for fiscal 2025 and a 1‑for‑20 reverse share split provide a catalyst narrative, yet the company’s cash burn, high leverage and lack of dividend sustainability keep the upside highly speculative.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Oversold RSI but still far below key moving averages
  • Negative earnings and high leverage
  • Extreme price volatility and near‑total historical drawdown

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong revenue growth and potential DCF upside
  • Continued cash flow deficits and debt pressure
  • Upcoming reverse split may improve per‑share pricing

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Significant valuation gap versus DCF fair value
  • High revenue growth trajectory if margins can be turned around
  • Potential strategic pivot in Chinese tech regulatory environment

Key Metrics & Analysis

Financial Health

Revenue Growth91.20%
Profit Margin-15.37%
ROE-277.51%
ROA-31.62%
Debt/Equity108.83
P/B Ratio1.4
Op. Cash Flow$-41201000
Free Cash Flow$5.5M
Industry P/E40.9

Technical Analysis

TrendBearish
RSI21.8
Support$1.08
Resistance$3.20
MA 20$1.72
MA 50$12.52
MA 200$38.99
MACDBullish
VolumeIncreasing
Fear & Greed Index93.32

Valuation

Fair Value$17.66
GradeUndervalued
TypeGrowth

Risk Assessment

Beta-1.80
Volatility543.33%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.